<DOC>
	<DOCNO>NCT01121666</DOCNO>
	<brief_summary>Ther purpose study show equivalence AFOLIA Gonal-f® regard number oocytes retrieved woman assist reproductive treatment .</brief_summary>
	<brief_title>Multi-centre Study Compare Efficacy Safety AFOLIA Gonal-f Women Assisted Reproductive Treatment</brief_title>
	<detailed_description />
	<mesh_term>Infertility</mesh_term>
	<mesh_term>Follicle Stimulating Hormone</mesh_term>
	<criteria>Age 20 38 year regular menstrual cycle 2535 day First second cycle present series ART BMI ≥ 18 ≤ 30 kg/m2 Basal FSH &lt; 10 IU/L ( cycle day 25 ) E2 level &lt; 50pg/mL ( &lt; 0.18 nmol/L ) day FSH administration Antral follicle count ( AFC ) ≥ 10 ≤ 25 follicle ( sum ovary ) Infertility due follow factor : tubal factor , mild endometriosis ( ASRM stage 12 ) , male factor , unexplained infertility Presence ovaries normal uterine cavity ( confirm transvaginal ultrasound within 6 month randomisation ) Willingness participate study comply study protocol Informed consent Presence pregnancy History ≥2 succeed ART cycle ( IVF and/or ICSI ) study cycle without clinical pregnancy Presence clinically significant systemic disease Presence chronic cardiovascular , hepatic , renal pulmonary disease Presence uncontrolled endocrine disorder Previous history presence severe ovarian hyperstimulation syndrome Presence polycystic ovary ( PCO ) Presence severe endometriosis ( ASRM stage 3 stage 4 ) hydrosalpinx Neoplasia , include tumor hypothalamus pituitary gland Abnormal bleeding undetermined origin History poor response gonadotropin treatment ( define few 5 oocyte retrieve previous attempt ) Male infertility without mobile spermatozoon ejaculate , need testicular epididymal sperm retrieval ( MESA/TESE/TESA ) Endocrine abnormality TSH prolactin level elevation outside reference range clinically relevant screen Any hormonal treatment within 1 month start FSH treatment ( exception levothyroxin ) History drug , nicotine alcohol abuse within last 12 month ( &gt; 10 cigarettes/day ) Administration investigational product within last month Clinically abnormal finding Visit 1 Planned PGS/PGD/PBB assist hatch Concomitant participation study protocol History extrauterine pregnancy previous 3 month Known allergy hypersensitivity progesterone excipients ( include peanut oil ) additional study medication ( GnRH agonist , vitrelle® , Utrogestan® ) Presence history thrombophlebitis thromboembolic disorder Presence history cerebral haemorrhage Presence history porphyria</criteria>
	<gender>Female</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>38 Years</maximum_age>
	<verification_date>March 2016</verification_date>
	<keyword>Assisted reproductive treatment</keyword>
	<keyword>Superovulation</keyword>
	<keyword>Follitropin alfa</keyword>
	<keyword>r-hFSH</keyword>
	<keyword>AFOLIA</keyword>
</DOC>